IMMUNOTHERAPY USING CYCLOSPORINE, INTERFERON GAMMA, AND INTERLEUKIN-2 AFTER HIGH-DOSE MYELOABLATIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN TREATING PATIENTS WITH REFRACTORY OR RELAPSED HODGKIN'S LYMPHOMA: